GODAVARI DRU Fact Sheet, GODAVARI DRU Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU Fact Sheet    (GDVD)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of GODAVARI DRU. For more details, see the GODAVARI DRU quarterly results and GODAVARI DRU share price and chart. For a sector overview, read our pharmaceuticals sector report.

GODAVARI DRU Price History

Price Rs 67.5
Mkt Cap Rs m 508
Vol '000 9.7
P/E X 10.8
P/CF X 16.1
EPS (TTM) Rs 6.2
% ch % -2.6
No. of shares m 7.53
% ch week % -9.3
% ch 1-mth % -7.9
% ch 12-mth % 90.7
52 week H/L Rs 83.6/32.6
(As on Sep 21, 2021 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GODAVARI DRU Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
GODAVARI DRU EQUITY SHARE DATA
High Rs9255483625 
Low Rs303430179 
Sales per share (Unadj.) Rs83.790.785.6110.9127.1 
Earnings per share (Unadj.) Rs1.82.41.11.62.7 
Diluted earnings per shareRs1.82.41.11.62.7 
Cash flow per share (Unadj.) Rs2.63.52.43.04.2 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs19.121.522.624.226.9 
Adj. book value per shareRs19.121.522.624.226.9 
Shares outstanding (eoy) m7.537.537.537.537.53 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.70.50.50.20.1 
Avg P/E ratio x34.018.535.416.46.4 
P/CF ratio (eoy) x23.212.816.28.64.1 
Price / Book Value ratio x3.22.11.71.10.6 
Dividend payout %00000 
Avg Mkt Cap Rs m460335293198129 
No. of employees `000NANANANANA 
Total wages/salary Rs m2224273534 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
GODAVARI DRU INCOME DATA
Net Sales Rs m630683644835957 
Other income Rs m28723 
Total revenues Rs m632691651838960 
Gross profit Rs m4552415560 
Depreciation Rs m68101112 
Interest Rs m1925242929 
Profit before tax Rs m2227131723 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m89553 
Profit after tax Rs m141881220 
Gross profit margin %7.17.76.36.66.3 
Effective tax rate %38.033.236.930.812.6 
Net profit margin %2.12.61.31.42.1 
GODAVARI DRU BALANCE SHEET DATA
Current assets Rs m404426473565608 
Current liabilities Rs m311335374462512 
Net working cap to sales %14.813.415.312.310.0 
Current ratio x1.31.31.31.21.2 
Inventory Days Days11111 
Debtors Days Days142129152148137 
Net fixed assets Rs m101131157172231 
Share capital Rs m7575757575 
"Free" reserves Rs m698795107127 
Net worth Rs m144162170183203 
Long term debt Rs m39446680112 
Total assets Rs m505557630737839 
Interest coverage x2.22.11.51.61.8 
Debt to equity ratio x0.30.30.40.40.6 
Sales to assets ratio x1.21.21.01.11.1 
Return on assets %6.47.85.25.65.9 
Return on equity %9.411.24.96.69.9 
Return on capital %22.125.415.917.716.6 
Exports to sales %1.71.01.32.00.2 
Imports to sales %62.555.158.464.760.2 
Exports (fob) Rs m1179162 
Imports (cif) Rs m394377377540576 
Fx inflow Rs m1179162 
Fx outflow Rs m395377378541577 
Net fx Rs m-384-371-369-525-575 
GODAVARI DRU CASH FLOW
From Operations Rs m -45 51 38 37 62 
From Investments Rs m -21 -30 -29 -23 -67 
From Financial Activity Rs m 70 -19 -1 -15 3 
Net Cashflow Rs m 4 2 7 -1 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 56.1%
Institution 0.5%
Non-Institution 43.4%
Total 100.0%
Free Float 43.9%
Pledged promoter holdings 14.5%
 

Company Information

REGD OFF 1-8-303/4, Mayfair, Sardar Patel Road, Secunderabad - 500003
E-MAIL info@godavaridrugs.com WEB www.godavaridrugs.com
TEL 040- 27849700/27844557 FAX 040- 27849859
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Cil Securities Ltd, 214 Raghava Ratna Towers Chirag Ali Lane, Abidas
YEAR OF INC: 1987 BSE CODE: 530317 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ZOTA HEALTH CARE  TTK HEALTHCARE  PARMAX PHARMA  ASPIRA PATHLAB & DIAGNOSTICS   TORRENT PHARMA  

Compare GODAVARI DRU With:   ZOTA HEALTH CARE  TTK HEALTHCARE  PARMAX PHARMA  ASPIRA PATHLAB & DIAGNOSTICS   TORRENT PHARMA  




Today's Market

4 Reasons Why Sensex Surged 514 Points Today(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a strong note.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GODAVARI DRU

  • Track your investment in GODAVARI DRU with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GODAVARI DRU

GODAVARI DRU - ADVANCED ENZYME TECHNOLOGIES COMPARISON

COMPARE GODAVARI DRU WITH

MARKET STATS